$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 52/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 52/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 123.92 | 334 | 41,389 | 30,327 | 30.7 K to 30.3 K (-1.09 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Durso Jerome Benedict | Chief Operating Off ... | Payment of Exercise | F | 123.92 | 1,151 | 142,632 | 30,661 | 31.8 K to 30.7 K (-3.62 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 123.92 | 309 | 38,291 | 16,098 | 16.4 K to 16.1 K (-1.88 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Kim Richard J | President US Comm & ... | Payment of Exercise | F | 123.92 | 340 | 42,133 | 16,407 | 16.7 K to 16.4 K (-2.03 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 123.92 | 669 | 82,902 | 24,847 | 25.5 K to 24.8 K (-2.62 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Kapadia Sandip | CFO and Treasurer | Payment of Exercise | F | 123.92 | 551 | 68,280 | 25,516 | 26.1 K to 25.5 K (-2.11 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Campagna Jason | Chief Medical Offic ... | Payment of Exercise | F | 123.92 | 150 | 18,588 | 7,035 | 7.2 K to 7 K (-2.09 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Campagna Jason | Chief Medical Offic ... | Payment of Exercise | F | 123.92 | 259 | 32,095 | 7,185 | 7.4 K to 7.2 K (-3.48 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 123.92 | 530 | 65,678 | 17,814 | 18.3 K to 17.8 K (-2.89 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Bright Lisa | President, Internat ... | Payment of Exercise | F | 123.92 | 388 | 48,081 | 18,344 | 18.7 K to 18.3 K (-2.07 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 21.50 | 100 | 2,150 | 30,084 | |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 123.92 | 1,166 | 144,491 | 466,829 | 468 K to 466.8 K (-0.25 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Payment of Exercise | F | 123.92 | 1,131 | 140,154 | 467,995 | 469.1 K to 468 K (-0.24 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 125.00 | 100 | 12,500 | 469,126 | 469.2 K to 469.1 K (-0.02 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 21.50 | 100 | 2,150 | 469,226 | 469.1 K to 469.2 K (+0.02 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 123.92 | 809 | 100,251 | 21,080 | 21.9 K to 21.1 K (-3.70 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 123.92 | 54 | 6,692 | 13,760 | 13.8 K to 13.8 K (-0.39 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Payment of Exercise | F | 123.92 | 364 | 45,107 | 13,814 | 14.2 K to 13.8 K (-2.57 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Sell | S | 117.16 | 259 | 30,344 | 10,580 | 10.8 K to 10.6 K (-2.39 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 123.92 | 106 | 13,136 | 10,839 | 10.9 K to 10.8 K (-0.97 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Ford David A | Chief Human Resourc ... | Payment of Exercise | F | 123.92 | 323 | 40,026 | 10,945 | 11.3 K to 10.9 K (-2.87 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Option Exercise | M | 54.63 | 262 | 14,313 | 20,779 | |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Payment of Exercise | F | 123.92 | 349 | 43,248 | 18,373 | 18.7 K to 18.4 K (-1.86 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Sell | S | 125.00 | 262 | 32,750 | 18,722 | 19 K to 18.7 K (-1.38 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Buy | M | 54.63 | 262 | 14,313 | 18,984 | 18.7 K to 19 K (+1.40 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Option Exercise | M | 58.74 | 54 | 3,172 | 2,883 | |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Option Exercise | M | 59.12 | 416 | 24,594 | 17,692 | |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Sell | S | 123.24 | 1,581 | 194,842 | 14,178 | 15.8 K to 14.2 K (-10.03 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Buy | M | 58.74 | 54 | 3,172 | 15,759 | 15.7 K to 15.8 K (+0.34 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Weyer Christian | EVP, Research & Dev ... | Buy | M | 59.12 | 416 | 24,594 | 15,705 | 15.3 K to 15.7 K (+2.72 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Option Exercise | M | 21.50 | 417 | 8,966 | 30,184 | |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Sell | S | 125.00 | 417 | 52,125 | 469,126 | 469.5 K to 469.1 K (-0.09 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | President & CEO | Buy | M | 21.50 | 417 | 8,966 | 469,543 | 469.1 K to 469.5 K (+0.09 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Option Exercise | M | 54.63 | 54 | 2,950 | 21,041 | |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Sell | S | 125.00 | 54 | 6,750 | 18,722 | 18.8 K to 18.7 K (-0.29 %) |
| Dec 30 2019 | ICPT | INTERCEPT PHARMACE ... | Cawkwell Gail | SVP, Med Affairs, S ... | Buy | M | 54.63 | 54 | 2,950 | 18,776 | 18.7 K to 18.8 K (+0.29 %) |